Hua Tong

864 total citations
35 papers, 607 citations indexed

About

Hua Tong is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Hua Tong has authored 35 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 8 papers in Physiology and 6 papers in Epidemiology. Recurrent topics in Hua Tong's work include Pain Mechanisms and Treatments (8 papers), Inflammasome and immune disorders (5 papers) and MicroRNA in disease regulation (3 papers). Hua Tong is often cited by papers focused on Pain Mechanisms and Treatments (8 papers), Inflammasome and immune disorders (5 papers) and MicroRNA in disease regulation (3 papers). Hua Tong collaborates with scholars based in China and United States. Hua Tong's co-authors include Hongbin Yuan, Mei Yang, Erliang Kong, Yongchang Li, Hailong Fu, Hao‐Wei Wang, Jian Li, Wenqian Li, Xiaoping Zhang and Yue Wang and has published in prestigious journals such as Brain, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Hua Tong

33 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hua Tong China 15 309 149 91 81 68 35 607
Changyin Yu China 17 320 1.0× 155 1.0× 74 0.8× 73 0.9× 87 1.3× 60 783
Nila Volpi Italy 16 313 1.0× 104 0.7× 49 0.5× 98 1.2× 89 1.3× 48 889
Lan N. Tu United States 14 424 1.4× 117 0.8× 71 0.8× 73 0.9× 122 1.8× 35 771
Paulina Gil-Kulik Poland 13 208 0.7× 162 1.1× 36 0.4× 72 0.9× 45 0.7× 41 567
Daochao Huang China 16 212 0.7× 140 0.9× 83 0.9× 96 1.2× 41 0.6× 34 543
Shunxing Zhu China 14 194 0.6× 75 0.5× 54 0.6× 43 0.5× 42 0.6× 36 483
Lanhai Lü China 14 307 1.0× 76 0.5× 65 0.7× 83 1.0× 55 0.8× 27 629
Marta Seco-Cervera Spain 16 306 1.0× 89 0.6× 92 1.0× 43 0.5× 68 1.0× 29 600
Yue Qiu China 13 189 0.6× 119 0.8× 48 0.5× 22 0.3× 72 1.1× 30 547
Haichun Ma China 17 358 1.2× 129 0.9× 99 1.1× 64 0.8× 41 0.6× 50 832

Countries citing papers authored by Hua Tong

Since Specialization
Citations

This map shows the geographic impact of Hua Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hua Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hua Tong more than expected).

Fields of papers citing papers by Hua Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hua Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hua Tong. The network helps show where Hua Tong may publish in the future.

Co-authorship network of co-authors of Hua Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Hua Tong. A scholar is included among the top collaborators of Hua Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hua Tong. Hua Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Mei, Erliang Kong, Xiaochen Zhang, et al.. (2025). CMPK2 facilitates pain sensitization by promoting the lactylation and deactivation of cGAS-STING pathway in neuropathic pain. Brain Behavior and Immunity. 128. 370–382. 1 indexed citations
2.
Tong, Hua, Yupeng Zhang, Shuo Li, et al.. (2025). Targeted codelivery of nitric oxide and hydrogen sulfide for enhanced antithrombosis efficacy. Bioactive Materials. 48. 29–42. 1 indexed citations
3.
Tong, Hua, Erliang Kong, Hailing Zhang, et al.. (2024). PRMT6 deficiency or inhibition alleviates neuropathic pain by decreasing glycolysis and inflammation in microglia. Brain Behavior and Immunity. 118. 101–114. 17 indexed citations
4.
Kong, Erliang, Hua Tong, Jian Li, et al.. (2024). HSV-1 reactivation results in post-herpetic neuralgia by upregulating Prmt6 and inhibiting cGAS-STING. Brain. 147(7). 2552–2565. 12 indexed citations
5.
Sun, Jian‐Wen, Hua Tong, Jieru Wang, et al.. (2024). Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality. Journal of Medicinal Chemistry. 67(3). 2095–2117. 11 indexed citations
6.
Tong, Hua, Lu Chen, Christophe Morisseau, et al.. (2024). Design and Synthesis of sEH/HDAC6 Dual-Targeting Inhibitors for the Treatment of Inflammatory Pain. Journal of Medicinal Chemistry. 67(15). 12887–12911. 8 indexed citations
7.
8.
Kong, Erliang, Yongchang Li, Peng Ma, et al.. (2023). Lyn‐mediated glycolysis enhancement of microglia contributes to neuropathic pain through facilitating IRF5 nuclear translocation in spinal dorsal horn. Journal of Cellular and Molecular Medicine. 27(12). 1664–1681. 16 indexed citations
9.
Tong, Hua, Xiaoyi Fan, Jian Li, et al.. (2022). BRD4 Inhibition Attenuates Inflammatory Pain by Ameliorating NLRP3 Inflammasome-Induced Pyroptosis. Frontiers in Immunology. 13. 837977–837977. 32 indexed citations
10.
Tong, Hua, Mei Yang, Erliang Kong, et al.. (2022). Huc-MSCs-derived exosomes attenuate inflammatory pain by regulating microglia pyroptosis and autophagy via the miR-146a-5p/TRAF6 axis. Journal of Nanobiotechnology. 20(1). 324–324. 104 indexed citations
11.
Wang, Chenfeng, Hua Tong, Haibin Wang, et al.. (2022). Inhibition of IL1R1 or CASP4 attenuates spinal cord injury through ameliorating NLRP3 inflammasome-induced pyroptosis. Frontiers in Immunology. 13. 963582–963582. 12 indexed citations
12.
Kong, Erliang, et al.. (2022). Glycometabolism Reprogramming of Glial Cells in Central Nervous System: Novel Target for Neuropathic Pain. Frontiers in Immunology. 13. 861290–861290. 29 indexed citations
13.
14.
Liu, Jinrong, et al.. (2019). A novel human monoclonal Trop2-IgG antibody inhibits ovarian cancer growth in vitro and in vivo. Biochemical and Biophysical Research Communications. 512(2). 276–282. 15 indexed citations
15.
Mao, Yuan, et al.. (2019). A fully chimeric IgG antibody for ROR1 suppresses ovarian cancer growth in vitro and in vivo. Biomedicine & Pharmacotherapy. 119. 109420–109420. 9 indexed citations
16.
Cai, Linlin, Yonghua Li, Qingqing Zhang, et al.. (2017). Salidroside protects rat liver against ischemia/reperfusion injury by regulating the GSK-3β/Nrf2-dependent antioxidant response and mitochondrial permeability transition. European Journal of Pharmacology. 806. 32–42. 47 indexed citations
17.
Li, Caixia, Le Wang, Hua Tong, et al.. (2016). Microsatellite analysis of genotype distribution patterns of Candida albicans vulvovaginal candidiasis in Nanjing, China and its association with pregnancy, age and clinical presentation. Archives of Gynecology and Obstetrics. 294(2). 291–297. 8 indexed citations
18.
Zhang, Huilin, et al.. (2014). The inhibitory effect of a new scFv/tP protein as siRNA delivery system to target hWAPL in cervical carcinoma. Molecular and Cellular Biochemistry. 391(1-2). 77–84. 9 indexed citations
19.
Tong, Hua, et al.. (2010). Effect of Wujijing Oral Liquid on menstrual disturbance of women. Journal of Ethnopharmacology. 128(3). 649–653. 12 indexed citations
20.
Tong, Hua, Rong Shen, Yiquan Wang, et al.. (2009). DNA Ploidy Cytometry Testing for Cervical Cancer Screening in China (DNACIC Trial): a Prospective Randomized, Controlled Trial. Clinical Cancer Research. 15(20). 6438–6445. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Changyin Yu Breakdown of academic impact, for papers by Nila Volpi Breakdown of academic impact, for papers by Lan N. Tu Breakdown of academic impact, for papers by Paulina Gil-Kulik Breakdown of academic impact, for papers by Daochao Huang Breakdown of academic impact, for papers by Shunxing Zhu Breakdown of academic impact, for papers by Lanhai Lü Breakdown of academic impact, for papers by Marta Seco-Cervera Breakdown of academic impact, for papers by Yue Qiu Breakdown of academic impact, for papers by Haichun Ma
Rankless by CCL
2026